N. Takahashi

Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.

C. Cordon-Cardo, S. Jhanwar, J. Bertino, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Regulation of pyridoxal-5′-phosphate level by biogenic amines in mouse brain

N. Hibi, K. Ohkawa, T. Asakura, 2006, Neurochemical Research.

Differentiation-dependent expression of I and sialyl I antigens in the developing lung of human embryos and in lung cancers.

S. Arii, N. Yanai, T. Tobe, 1990, Cancer research.

Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells.

T. Inoue, K. Takada, T. Asakura, 1997, Anti-cancer drugs.

Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells.

T. Inoue, S. Yokoyama, K. Takada, 1997, British Journal of Cancer.

Inhibitory effects of 3-nitro-2,4,6-trihydroxybenzamides on Epstein-Barr virus early antigen induction.

H. Nishino, M. Kozuka, H. Tokuda, 1991, Cancer letters.

Sequence-dependent synergistic cytotoxicity of ecteinascidin-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo.

Debabrata Banerjee, T. Chou, D. Banerjee, 2002, Cancer research.

Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells.

D. Banerjee, J. Bertino, K. Scotto, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.